None the less, the pathogenic role of JAK/STAT signalling pathway has been documented in cancer (Chan et al, 2004), the role of JAK2/STAT3 in the pathogenesis of ovarian cancer is still unknown. This evidence concerns the gene STAT3 and ovarian carcinoma.